Share on StockTwits

Analysts at ISI Group lifted their target price on shares of Cardinal Health (NYSE:CAH) from $77.00 to $78.50 in a research report issued to clients and investors on Monday. The firm currently has a “buy” rating on the stock. ISI Group’s target price indicates a potential upside of 8.47% from the company’s current price.

A number of other analysts have also recently weighed in on CAH. Analysts at Robert W. Baird raised their price target on shares of Cardinal Health from $80.00 to $82.00 in a research note on Wednesday, July 9th. Separately, analysts at Zacks downgraded shares of Cardinal Health from an “outperform” rating to a “neutral” rating in a research note on Wednesday, June 11th. They now have a $74.00 price target on the stock. Finally, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Cardinal Health in a research note on Monday, June 2nd. They now have a $76.00 price target on the stock. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Cardinal Health currently has an average rating of “Buy” and an average target price of $76.84.

In other Cardinal Health news, CAO Stuart G. Laws sold 21,266 shares of Cardinal Health stock on the open market in a transaction that occurred on Thursday, July 24th. The stock was sold at an average price of $72.50, for a total transaction of $1,541,785.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Shares of Cardinal Health (NYSE:CAH) traded down 4.39% on Monday, hitting $69.19. 3,116,576 shares of the company’s stock traded hands. Cardinal Health has a 52-week low of $49.65 and a 52-week high of $74.40. The stock has a 50-day moving average of $70.22 and a 200-day moving average of $69.24. The company has a market cap of $23.539 billion and a P/E ratio of 72.37.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Monday, August 4th. The company reported $0.83 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter in the prior year, the company posted $0.79 earnings per share. The company’s quarterly revenue was down 9.9% on a year-over-year basis. On average, analysts predict that Cardinal Health will post $3.82 earnings per share for the current fiscal year.

Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.